MiNK Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell INKT and other ETFs, options, and stocks.About INKT
MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded in 2017 and is headquartered in New York, NY.
CEOJennifer S. Buell
CEOJennifer S. Buell
Employees23
Employees23
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2017
Founded2017
Employees23
Employees23
INKT Key Statistics
Market cap65.36M
Market cap65.36M
Price-Earnings ratio-4.88
Price-Earnings ratio-4.88
Dividend yield—
Dividend yield—
Average volume43.68K
Average volume43.68K
High today$14.45
High today$14.45
Low today$14.15
Low today$14.15
Open price$14.15
Open price$14.15
Volume701.00
Volume701.00
52 Week high$76.00
52 Week high$76.00
52 Week low$4.56
52 Week low$4.56
INKT News
TipRanks 3d
Mink Therapeutics’ Earnings Call: Clinical Progress Amid Financial ChallengesMink Therapeutics, Inc. ((INKT)) has held its Q2 earnings call. Read on for the main highlights of the call. Elevate Your Investing Strategy: Take advantage of...
People also own
Based on the portfolios of people who own INKT. This list is generated using Robinhood data, and it’s not a recommendation.